Take­da on­col­o­gy vet drills down the 'ba­sic­s' at cell ther­a­py start­up; Sarep­ta pro­motes new R&D chief

Kathryn Cor­zo — an on­col­o­gy vet­er­an and the pro­gram head be­hind Sanofi’s mul­ti­ple myelo­ma mon­o­clon­al an­ti­body isat­ux­imab — is now in the C-suite.


Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.